Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultrasound Neural and Immunomodulation Treatment Evaluation Study (UMN-SW) for COVID-19 With Wearable Ultrasound Device

NCT04854798 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT04854798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04854798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultrasound Neural and Immunomodulation Treatment Evaluation Study (UMN-SW) for COVID-19 With Wearable Ultrasound Device
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Completed
Start date
April 29, 2021
Completion date
February 11, 2022
Enrollment
58 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, cytokine storm, inflammation